SCHEDULE 13G/A: Paul Mann Discloses 10.8% Beneficial Ownership Stake in ASP Isotopes Inc.
Beneficial Ownership Report
Paul E. Mann has filed an amended Schedule 13G, reporting a beneficial ownership of 10.8% in ASP Isotopes Inc.'s Common Stock as of December 31, 2024.
Summary
- Paul E. Mann, a citizen of the United Kingdom, has filed an Amendment No. 2 to Schedule 13G regarding his beneficial ownership in ASP Isotopes Inc.
- As of December 31, 2024, Mr. Mann beneficially owns an aggregate of 7,712,982 shares of ASP Isotopes Inc. Common Stock.
- This ownership represents 10.8% of the company's outstanding Common Stock.
- The calculation of the percentage is based on 71,390,107 outstanding shares as of November 13, 2024, as reported in the Issuer's Form 10-Q filed on November 19, 2024.
- Mr. Mann holds sole voting power and sole dispositive power over all 7,712,982 shares.
- The total beneficial ownership includes 6,824,093 shares held directly by Paul Mann and 1,104,889 shares issuable upon the exercise of warrants exercisable within 60 days of December 31, 2024.
Sentiment
Score: 6
Explanation: The document is a factual report of beneficial ownership. The disclosure of a significant stake (10.8%) by an individual can be viewed positively as a sign of confidence, hence a slightly positive score, but it contains no operational or financial performance details.
Positives
- A significant beneficial ownership stake by an individual like Paul E. Mann (10.8%) can signal confidence in the company's future prospects.
- The inclusion of shares issuable from warrants indicates a long-term interest and potential for increased direct ownership.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by an individual, which is common across various industries. It does not provide specific industry trends but indicates a notable investment in the isotopes sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant individual stake may be viewed positively, potentially signaling confidence in the company's value and future, which could influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 2024-11-13 | Date as of which 71,390,107 outstanding shares of ASP Isotopes Inc. were reported in the Issuer's Form 10-Q. |
| 2024-11-19 | Date ASP Isotopes Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2024-12-31 | Date of event which requires the filing of this Schedule 13G statement, reflecting Paul E. Mann's beneficial ownership. |
| 2025-02-14 | Date the Schedule 13G statement was signed by Paul E. Mann. |
Keywords
ASP Isotopes Inc., Paul E. Mann, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Shareholder Stake, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.